VOCABRIA oral tablets, to be used for short time intervals along with CABENUVA, have also been authorised by Wellness copyright. These approvals are the first for CABENUVA and VOCABRIA anywhere on the earth.​The presence of the ApoE εfour allele can be associated with cerebral amyloid angiopathy, which has an increased possibility for intracereb